Table 3.
Clinical outcomes for patients with ostial LAD versus crossover
| Variables | Overall Total = 175 | Ostial LAD n = 150 | Crossover to LM n = 25 |
|---|---|---|---|
| Mortality (1 year) % (CI) | 7.43 (5.45-9.41) | 7.3 (5.2-9.4) | 8 (2.6-13.4) |
| Mortality (5 year) % (CI) | 11.71 (9.13-14.29) | 9.9 (7.3-12.5) | 22.5 (13.5-31.5) |
| MACE (1 Year) % (CI) | 13.1 (10.5-15.7) | 13.3 (10.5-16.1) | 12 (5.5-18.5) |
| MACE (5 year) % (CI) | 20.2 (17-23.4) | 19.3 (15.9-22.7) | 25.9 (16.6-35.2) |
| TLR (Total) n (%) | 12 (6.9) | 11 (7.3) | 1 (4) |
| TVR (Total) n (%) | 15 (8.6) | 12 (8) | 3 (12) |
| Restenosis >50% (Total) n (%) | 16 (9.1) | 15 (10) | 1 (4) |
LAD = Left anterior descending; LM = Left Main; MACE = major adverse cardiac events; TLR = target lesion revascularization; TVR = target vessel revacularization.